Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2020

01-02-2020 | Care | Short Research Report

Feasibility of an interprofessional collaborative osteoporosis screening programme in Malaysia

Authors: Li Shean Toh, Pauline Siew Mei Lai, Bee Yean Low, Kok Thong Wong, Claire Anderson

Published in: International Journal of Clinical Pharmacy | Issue 1/2020

Login to get access

Abstract

Background Population screening for osteoporosis using bone mineral density scan is not feasible in Malaysia as this test is costly. Hence, there is a need to develop a more efficient method to screen for osteoporosis.Objectives To determine the feasibility of an interprofessional collaborative osteoporosis screening programme (IPC-OSP). Methods Postmenopausal women aged ≥ 50 years, who had not been diagnosed with osteoporosis were recruited from a primary care clinic from June to August 2014. Patients were assessed for their osteoporosis risk and were counselled on prevention methods. Patients at risk were referred to the doctor with a recommendation for a bone mineral density (BMD) scan. Results Fifty out of 55 patients were recruited (response rate = 90.9%). A total 26/50 (52.0%) went for a bone mineral density scan, none were osteoporotic, 17/50 (34%) were osteopenic, 2/50 (4.0%), were started on osteoporosis medications and 14/50 (28%) modified their lifestyle to improve bone health or started on calcium supplements. Osteoporosis knowledge significantly increased from baseline to month two (46.3 ± 21.4 vs. 79.1 ± 14.3, p < 0.001). Patients had a satisfaction score of 89.8 ± 12.4. Follow-up rates were 83.9% and 100% at months 1 (BMD appointment) and 2 (phone follow up), respectively. The intervention was successfully coordinated. Data entry was determined to be viable based on the researchers’ experience. Conclusion The interprofessional collaborative osteoporosis screening programme was found to be feasible in Malaysia.
Literature
1.
go back to reference Cosman F, Lindsay R, LeBoff MS, Jan de Beur S, Tanner B. National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2014. Cosman F, Lindsay R, LeBoff MS, Jan de Beur S, Tanner B. National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2014.
2.
go back to reference Tickle-Degnen L. Nuts and bolts of conducting feasibility studies. The American Journal of Occupational Therapy. 2013;67:171–6.CrossRef Tickle-Degnen L. Nuts and bolts of conducting feasibility studies. The American Journal of Occupational Therapy. 2013;67:171–6.CrossRef
3.
go back to reference Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol. 2010;10(1):1.CrossRef Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol. 2010;10(1):1.CrossRef
4.
go back to reference Koh LKH, Sedrine WB, Torralba TP, Kung AW, Fujiwara S, Chan SP, et al. A simple tool to identify Asian women at increased risk of osteoporosis. Osteoporos Int. 2001;12:699–705.CrossRef Koh LKH, Sedrine WB, Torralba TP, Kung AW, Fujiwara S, Chan SP, et al. A simple tool to identify Asian women at increased risk of osteoporosis. Osteoporos Int. 2001;12:699–705.CrossRef
5.
go back to reference Kanis JA. FRAX WHO Fracture Risk Assessment Tool. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK. 2014. http://www.shef.ac.uk/FRAX/. Accessed 22 December 2014. Kanis JA. FRAX WHO Fracture Risk Assessment Tool. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK. 2014. http://​www.​shef.​ac.​uk/​FRAX/​. Accessed 22 December 2014.
6.
go back to reference Toh LS, Lai PS, Wu DB, Wong KT, Low BY, Anderson C. The Development and Validation of the Osteoporosis Prevention and Awareness Tool (OPAAT) in Malaysia. PLoS ONE. 2015;10(5):e0124553.CrossRef Toh LS, Lai PS, Wu DB, Wong KT, Low BY, Anderson C. The Development and Validation of the Osteoporosis Prevention and Awareness Tool (OPAAT) in Malaysia. PLoS ONE. 2015;10(5):e0124553.CrossRef
7.
go back to reference Toh LS, Lai PSM, Wong KT, Tan ATB, Low BY, Anderson C, et al. The development and validation of the Satisfaction Questionnaire for Osteoporosis Prevention in Malaysia. Patient Preference and Adherence. 2014;8:1365–81.PubMedPubMedCentral Toh LS, Lai PSM, Wong KT, Tan ATB, Low BY, Anderson C, et al. The development and validation of the Satisfaction Questionnaire for Osteoporosis Prevention in Malaysia. Patient Preference and Adherence. 2014;8:1365–81.PubMedPubMedCentral
8.
go back to reference Toh LS, Lai PSM, Wong KT, Low BY, Anderson C. What are the barriers encountered while screening for osteoporosis in a government university hospital primary care setting? Preliminary results of a qualitative study on Malaysian nurses views. Osteoporos Int. 2012;23(Suppl 7):S777. Toh LS, Lai PSM, Wong KT, Low BY, Anderson C. What are the barriers encountered while screening for osteoporosis in a government university hospital primary care setting? Preliminary results of a qualitative study on Malaysian nurses views. Osteoporos Int. 2012;23(Suppl 7):S777.
9.
go back to reference Toh LS, Lai PSM, Low BY, Wong KT, Anderson C. The development of a pharmacist-led osteoporosis screening intervention using the behavioural change wheel. International Journal of Pharmacy Practice. 2016:30. Toh LS, Lai PSM, Low BY, Wong KT, Anderson C. The development of a pharmacist-led osteoporosis screening intervention using the behavioural change wheel. International Journal of Pharmacy Practice. 2016:30.
10.
go back to reference Elias MN, Burden AM, Cadarette SM. The impact of pharmacist interventions on osteoporosis management: a systematic review. Osteoporos Int. 2011;22(10):2587–96.CrossRef Elias MN, Burden AM, Cadarette SM. The impact of pharmacist interventions on osteoporosis management: a systematic review. Osteoporos Int. 2011;22(10):2587–96.CrossRef
11.
go back to reference Heilmann RMF, Friesleben CR, Billups SJ. Impact of a pharmacist-directed intervention in postmenopausal women after fracture. American Journal of Health-System Pharmacy. 2012;69(6):504–9.CrossRef Heilmann RMF, Friesleben CR, Billups SJ. Impact of a pharmacist-directed intervention in postmenopausal women after fracture. American Journal of Health-System Pharmacy. 2012;69(6):504–9.CrossRef
12.
go back to reference Yuksel N, Majumdar SR, Biggs C, Tsuyuki RT. Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial. Osteoporos Int. 2010;21(3):391–8.CrossRef Yuksel N, Majumdar SR, Biggs C, Tsuyuki RT. Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial. Osteoporos Int. 2010;21(3):391–8.CrossRef
Metadata
Title
Feasibility of an interprofessional collaborative osteoporosis screening programme in Malaysia
Authors
Li Shean Toh
Pauline Siew Mei Lai
Bee Yean Low
Kok Thong Wong
Claire Anderson
Publication date
01-02-2020
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2020
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-019-00960-x

Other articles of this Issue 1/2020

International Journal of Clinical Pharmacy 1/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.